Now showing items 1-2 of 2

  • Hough, Denise; Bellingham, Michelle; Haraldsen, Ira Hebold; McLaughlin, Mark; Robinson, Jane E.; Solbakk, Anne-Kristin; Evans, Neil P. (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2017)
    Chronic gonadotropin-releasing hormone agonist (GnRHa) administration is used where suppression of hypothalamic-pituitary-gonadal axis activity is beneficial, such as steroid-dependent cancers, early onset gender dysphoria, ...
  • Hough, Denise; Bellingham, Michelle; Haraldsen, Ira Hebold; McLaughlin, Mark; Rennie, Michael; Robinson, Jane E.; Solbakk, Anne-Kristin; Evans, Neil P. (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2017)
    Chronic gonadotropin-releasing hormone agonist (GnRHa) is used therapeutically to block activity within the reproductive axis through down-regulation of GnRH receptors within the pituitary gland. GnRH receptors are also ...